Literature DB >> 18765722

RipA, a cytoplasmic membrane protein conserved among Francisella species, is required for intracellular survival.

James R Fuller1, Robin R Craven, Joshua D Hall, Todd M Kijek, Sharon Taft-Benz, Thomas H Kawula.   

Abstract

Francisella tularensis is a highly virulent bacterial pathogen that invades and replicates within numerous host cell types, including macrophages and epithelial cells. In an effort to better understand this process, we screened a transposon insertion library of the F. tularensis live vaccine strain (LVS) for mutant strains that invaded but failed to replicate within alveolar epithelial cell lines. One such strain isolated from this screen contained an insertion in the gene FTL_1914, which is conserved among all sequenced Francisella species yet lacks significant homology to any gene with known function. A deletion strain lacking FTL_1914 was constructed. This strain did not replicate in either epithelial or macrophage-like cells, and intracellular replication was restored by the wild-type allele in trans. Based on the deletion mutant phenotype, FTL_1914 was termed ripA (required for intracellular proliferation, factor A). Following uptake by J774.A1 cells, F. tularensis LVS Delta ripA colocalized with LAMP-1 then escaped the phagosome at the same rate and frequency as wild-type LVS-infected cells. Electron micrographs of the F. tularensis LVS Delta ripA mutant demonstrated the reentry of the mutant bacteria into double membrane vacuoles characteristic of autophagosomes in a process that was not dependent on replication. The F. tularensis LVS Delta ripA mutant was significantly impaired in its ability to persist in the lung and in its capacity to disseminate and colonize the liver and spleen in a mouse model of pulmonary tularemia. The RipA protein was expressed during growth in laboratory media and localized to the cytoplasmic membrane. Thus, RipA is a cytoplasmic membrane protein conserved among Francisella species that is required for intracellular replication within the host cell cytoplasm as well as disease progression, dissemination, and virulence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765722      PMCID: PMC2573376          DOI: 10.1128/IAI.00475-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

1.  Large tularaemia outbreak in Varmland, central Sweden, 2006.

Authors:  Olle Wik
Journal:  Euro Surveill       Date:  2006-09-21

2.  Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses.

Authors:  Güven Celebi; Fatma Baruönü; Ferruh Ayoğlu; Fikret Cinar; Aynur Karadenizli; Mehmet Birol Uğur; Suna Gedikoğlu
Journal:  Jpn J Infect Dis       Date:  2006-08       Impact factor: 1.362

3.  A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice.

Authors:  J E Quarry; K E Isherwood; S L Michell; H Diaper; R W Titball; P C F Oyston
Journal:  Vaccine       Date:  2006-12-08       Impact factor: 3.641

4.  Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication.

Authors:  Claire Checroun; Tara D Wehrly; Elizabeth R Fischer; Stanley F Hayes; Jean Celli
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

5.  Type IV pili-mediated secretion modulates Francisella virulence.

Authors:  Anthony J Hager; Diana L Bolton; Mark R Pelletier; Mitchell J Brittnacher; Larry A Gallagher; Rajinder Kaul; Shawn J Skerrett; Samuel I Miller; Tina Guina
Journal:  Mol Microbiol       Date:  2006-10       Impact factor: 3.501

6.  Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence.

Authors:  Horacio Gil; Gabrielle J Platz; Colin A Forestal; Michael Monfett; Chandra Shekhar Bakshi; Timothy J Sellati; Martha B Furie; Jorge L Benach; David G Thanassi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

7.  The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host cell.

Authors:  Patricia S Romano; Maximiliano G Gutierrez; Walter Berón; Michel Rabinovitch; María I Colombo
Journal:  Cell Microbiol       Date:  2006-11-03       Impact factor: 3.715

8.  Francisella tularensis replicates within alveolar type II epithelial cells in vitro and in vivo following inhalation.

Authors:  Joshua D Hall; Robin R Craven; James R Fuller; Raymond J Pickles; Thomas H Kawula
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

9.  Genetic tools for highly pathogenic Francisella tularensis subsp. tularensis.

Authors:  Eric D LoVullo; Lani A Sherrill; Lanyn L Perez; Martin S Pavelka
Journal:  Microbiology       Date:  2006-11       Impact factor: 2.777

10.  The Francisella pathogenicity island protein IglA localizes to the bacterial cytoplasm and is needed for intracellular growth.

Authors:  Olle M de Bruin; Jagjit S Ludu; Francis E Nano
Journal:  BMC Microbiol       Date:  2007-01-17       Impact factor: 3.605

View more
  39 in total

1.  Exploiting a natural auxotrophy for genetic selection.

Authors:  Elizabeth Ramage; Larry Gallagher; Colin Manoil
Journal:  Appl Environ Microbiol       Date:  2012-06-01       Impact factor: 4.792

2.  Deletion of ripA alleviates suppression of the inflammasome and MAPK by Francisella tularensis.

Authors:  Max Tze-Han Huang; Brittany L Mortensen; Debra J Taxman; Robin R Craven; Sharon Taft-Benz; Todd M Kijek; James R Fuller; Beckley K Davis; Irving Coy Allen; Willie June Brickey; Denis Gris; Haitao Wen; Thomas H Kawula; Jenny Pan-Yun Ting
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

3.  Effects of the putative transcriptional regulator IclR on Francisella tularensis pathogenesis.

Authors:  Brittany L Mortensen; James R Fuller; Sharon Taft-Benz; Todd M Kijek; Cheryl N Miller; Max T H Huang; Thomas H Kawula
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

4.  IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis.

Authors:  Timothy J Bauler; Jennifer C Chase; Catharine M Bosio
Journal:  J Immunol       Date:  2011-07-13       Impact factor: 5.422

Review 5.  Life on the inside: the intracellular lifestyle of cytosolic bacteria.

Authors:  Katrina Ray; Benoit Marteyn; Philippe J Sansonetti; Christoph M Tang
Journal:  Nat Rev Microbiol       Date:  2009-05       Impact factor: 60.633

6.  Elevated AIM2-mediated pyroptosis triggered by hypercytotoxic Francisella mutant strains is attributed to increased intracellular bacteriolysis.

Authors:  Kaitian Peng; Petr Broz; Jonathan Jones; Lydia-Marie Joubert; Denise Monack
Journal:  Cell Microbiol       Date:  2011-08-24       Impact factor: 3.715

7.  Microinjection of Francisella tularensis and Listeria monocytogenes reveals the importance of bacterial and host factors for successful replication.

Authors:  Lena Meyer; Jeanette E Bröms; Xijia Liu; Martin E Rottenberg; Anders Sjöstedt
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

8.  Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia.

Authors:  Sivakumar Periasamy; Anju Singh; Bikash Sahay; Tabassum Rahman; Paul J Feustel; Giang H Pham; Edmund J Gosselin; Timothy J Sellati
Journal:  J Leukoc Biol       Date:  2011-07-01       Impact factor: 4.962

9.  Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112.

Authors:  Joshua D Hall; Matthew D Woolard; Bronwyn M Gunn; Robin R Craven; Sharon Taft-Benz; Jeffrey A Frelinger; Thomas H Kawula
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

10.  Environmental and intracellular regulation of Francisella tularensis ripA.

Authors:  James R Fuller; Todd M Kijek; Sharon Taft-Benz; Thomas H Kawula
Journal:  BMC Microbiol       Date:  2009-10-12       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.